Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Low IGF-I in synovial fluid and serum in patients with aseptic prosthesis loosening.

Andersson MK, Stark A, Anissian L, Mohan S, Tsai JA.

Acta Orthop. 2005 Jun;76(3):320-5.

PMID:
16156457
2.

High levels of substance P and CGRP in pseudosynovial fluid from patients with aseptic loosening of their hip prosthesis.

Qian Y, Zeng BF, Zhang XL, Jiang Y.

Acta Orthop. 2008 Jun;79(3):342-5. doi: 10.1080/17453670710015238.

PMID:
18622837
3.

Local and systemic activation of the mononuclear phagocyte system in aseptic loosening of total hip arthroplasty.

Flecher X, Rolland C, Rixrath E, Argenson JN, Robert P, Bongrand P, Wendling S, Vitte J.

J Clin Immunol. 2009 Sep;29(5):681-90. doi: 10.1007/s10875-009-9305-9. Epub 2009 Jun 18.

PMID:
19536644
4.

[Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts].

Gallo J, Zdařilová A, Rajnochová Svobodová A, Ulrichová J, Radová L, Smižanský M.

Acta Chir Orthop Traumatol Cech. 2010 Oct;77(5):416-24. Czech.

PMID:
21040654
5.

Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.

Beraudi A, Stea S, Cremonini S, Visentin M, Toni A.

Artif Organs. 2009 Jul;33(7):538-43. doi: 10.1111/j.1525-1594.2009.00736.x.

PMID:
19566730
6.

Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage.

Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, Hintz RL, Maroudas A.

Arch Biochem Biophys. 1995 Dec 1;324(1):173-88.

PMID:
7503553
7.

Synovial fluid from loose hip arthroplasties inhibits human osteoblasts.

Andersson MK, Anissian L, Stark A, Bucht E, Felländer-Tsai L, Tsai JA.

Clin Orthop Relat Res. 2000 Sep;(378):148-54.

PMID:
10986989
8.

Tenascin-C levels in pseudosynovial fluid of loose hip prostheses.

Hasegawa M, Sudo A, Nagakura T, Hirata H, Kinoshita N, Yoshida T, Uchida A.

Scand J Rheumatol. 2005 Nov-Dec;34(6):464-8.

PMID:
16393770
9.

Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.

Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG.

J Clin Endocrinol Metab. 1996 Jan;81(1):150-5.

PMID:
8550744
10.

Insulin-like growth factors I and II in the aseptic loosening of total hip implants.

Waris V, Zhao DS, Leminen H, Santavirta S, Takagi M, Nordsletten L, Konttinen YT.

Scand J Rheumatol. 2004;33(6):428-31.

PMID:
15794204
11.

Effects of synovial fluid from aseptic prosthesis loosening on collagen production in osteoblasts.

Tsai JA, Andersson MK, Ivarsson M, Granberg B, Stark A.

Int Orthop. 2009 Jun;33(3):873-7. doi: 10.1007/s00264-008-0533-z. Epub 2008 Mar 19.

12.

Increased levels of IGF-I and IGFBP-3 in synovial fluids of patients with rheumatoid arthritis.

Matsumoto T, Yamashita S, Rosenfeld RG.

Endocr J. 1998 Apr;45 Suppl:S141-4. No abstract available.

13.

Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis.

Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M.

J Arthroplasty. 2005 Dec;20(8):1049-54.

PMID:
16376262
14.

High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.

Takei I, Takagi M, Ida H, Ogino T, Santavirta S, Konttinen YT.

J Rheumatol. 2000 Apr;27(4):894-9.

PMID:
10782812
15.

Hyaluronan in synovial fluid of patients with loose total hip prosthesis. Comparison with hyaluronan in patients with hip osteoarthritis and idiopathic osteonecrosis of femoral head.

Yamada H, Morita M, Henmi O, Miyauchi S, Yoshida Y, Kikuchi T, Terada N, Washimi O, Washimi Y, Seki T.

Arch Orthop Trauma Surg. 2000;120(9):521-4.

PMID:
11011673
16.

Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.

Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.

Scand J Clin Lab Invest. 2007;67(5):553-9.

PMID:
17763192
17.

Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.

Schlenska-Lange A, Knüpfer H, Lange TJ, Kiess W, Knüpfer M.

Anticancer Res. 2008 Mar-Apr;28(2A):1055-60. Erratum in: Anticancer Res. 2008 May-Jun;28(3b):1965.

18.
19.

Production of platelet-derived growth factor in aseptic loosening of total hip replacement.

Xu JW, Konttinen YT, Li TF, Waris V, Lassus J, Matucci-Cerinic M, Sorsa T, Santavirta TS.

Rheumatol Int. 1998;17(6):215-21.

PMID:
9592860
20.

The effect of laparoscopy on the IGF system in patients diagnosed with acute cholecystitis.

Baricević I, Jones DR, Malenković V, Nedić O.

Clin Endocrinol (Oxf). 2006 Sep;65(3):373-9.

PMID:
16918959

Supplemental Content

Support Center